{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:15:47Z","timestamp":1789431347328,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"am","delay-in-days":267,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bbagen.2022.130149","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T04:48:54Z","timestamp":1650862134000},"page":"130149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Esomeprazole covalently interacts with the cardiovascular enzyme dimethylarginine dimethylaminohydrolase: Insights into the cardiovascular risk of proton pump inhibitors"],"prefix":"10.1016","volume":"1866","author":[{"given":"Clyde A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Ebrahimpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Novikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron O.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antrix","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Saltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Malovannaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.V. Venkataram","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohannes T.","family":"Ghebre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2022.130149_bb0005","author":"U.S. Food and Drug Administration (FDA)"},{"key":"10.1016\/j.bbagen.2022.130149_bb0010","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bbagen.2022.130149_bb0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of Proton Pump Inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbagen.2022.130149_bb0020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/phar.2235","article-title":"Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study","volume":"39","author":"Hart","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbagen.2022.130149_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitor usage and the risk of myocardial infarction in the general population","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2022.130149_bb0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine","volume":"128","author":"Ghebremariam","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2022.130149_bb0035","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","article-title":"Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems","volume":"293","author":"Palm","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbagen.2022.130149_bb0040","doi-asserted-by":"crossref","first-page":"40449","DOI":"10.1074\/jbc.M104056200","article-title":"Structural and functional characterization of the Zn(II) site in dimethylargininase-1 (DDAH-1) from bovine brain. Zn(II) release activates DDAH-1","volume":"276","author":"Knipp","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2022.130149_bb0045","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1021\/bi972312t","article-title":"Characterization of dimethylargininase from bovine brain: evidence for a zinc binding site","volume":"37","author":"Bogumil","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2022.130149_bb0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/90387","article-title":"Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase","volume":"8","author":"Murray-Rust","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbagen.2022.130149_bb0055","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.str.2006.03.006","article-title":"Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: a basis for the design of specific inhibitors","volume":"14","author":"Frey","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.bbagen.2022.130149_bb0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2006.06.007","article-title":"Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential","volume":"113","author":"Krause","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbagen.2022.130149_bb0065","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1515\/CCLM.2005.196","article-title":"Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality","volume":"43","author":"Boger","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbagen.2022.130149_bb0070","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.108.838268","article-title":"Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community","volume":"119","author":"Boger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbagen.2022.130149_bb0075","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1021\/ja049607w","article-title":"Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors","volume":"126","author":"Shin","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2022.130149_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors","volume":"19","author":"Shin","year":"2013","journal-title":"J. Neurogastroenterol. Motility"},{"key":"10.1016\/j.bbagen.2022.130149_bb0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","article-title":"Disruption of methylarginine metabolism impairs vascular homeostasis","volume":"13","author":"Leiper","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2022.130149_bb0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/1087057112441521","article-title":"Development of a Dimethylarginine Dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening","volume":"17","author":"Ghebremariam","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bbagen.2022.130149_bb0095","doi-asserted-by":"crossref","first-page":"20572","DOI":"10.1074\/jbc.M000440200","article-title":"Multiple zinc binding sites in retinal rod cGMP phosphodiesterase, PDE6alpha beta","volume":"275","author":"He","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2022.130149_bb0100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0003-2697(69)80008-4","article-title":"Modified methods for the determination of carbamyl aspartate","volume":"32","author":"Prescott","year":"1969","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2022.130149_bb0105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/1087057111417712","article-title":"A continuous, fluorescent, high-throughput assay for human dimethylarginine dimethylaminohydrolase-1","volume":"16","author":"Linsky","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bbagen.2022.130149_bb0110","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1021\/bi047407r","article-title":"Characterization of a transient covalent adduct formed during dimethylarginine dimethylaminohydrolase catalysis","volume":"44","author":"Stone","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2022.130149_bb0115","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1515\/CCLM.2004.257","article-title":"Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay","volume":"42","author":"Schulze","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbagen.2022.130149_bb0120","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1006\/jmbi.1994.1052","article-title":"Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins","volume":"235","author":"Abagyan","year":"1994","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2022.130149_bb0125","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcc.540150503","article-title":"ICM: a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation","volume":"15","author":"Abagyan","year":"1994","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2022.130149_bb0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.bbagen.2022.130149_bb0135","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.bbagen.2022.130149_bb0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.bbagen.2022.130149_bb0145","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.bbagen.2022.130149_bb0150","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1021\/acs.analchem.8b03829","article-title":"Quantitative determination of protein-ligand affinity by size exclusion chromatography directly coupled to high-resolution native mass spectrometry","volume":"91","author":"Ren","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbagen.2022.130149_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00223-008-9188-4","article-title":"Increase in vertebral fracture risk in postmenopausal women using omeprazole","volume":"84","author":"Roux","year":"2009","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bbagen.2022.130149_bb0160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","article-title":"Proton-pump inhibitors and risk of fractures: an update meta-analysis","volume":"27","author":"Zhou","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bbagen.2022.130149_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2690","article-title":"Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study","volume":"342","author":"Charlot","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.bbagen.2022.130149_bb0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1567205011310040001","article-title":"Asymmetric dimethylarginine: a possible link between vascular disease and dementia","volume":"10","author":"Asif","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbagen.2022.130149_bb0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.niox.2018.06.004","article-title":"Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease","volume":"78","author":"Liu","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bbagen.2022.130149_bb0180","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehp061","article-title":"Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbagen.2022.130149_bb0185","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1161\/01.STR.0000231640.32543.11","article-title":"ADMA increases arterial stiffness and decreases cerebral blood flow in humans","volume":"37","author":"Kielstein","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.bbagen.2022.130149_bb0190","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2022.130149_bb0195","doi-asserted-by":"crossref","first-page":"58801","DOI":"10.18632\/oncotarget.18522","article-title":"Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagen.2022.130149_bb0200","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/j.1572-0241.2007.01509.x","article-title":"Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion","volume":"102","author":"Metz","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2022.130149_bb0205","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s10637-014-0159-5","article-title":"A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin","volume":"32","author":"Brana","year":"2014","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bbagen.2022.130149_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1358863X14568444","article-title":"Proton pump inhibitors and vascular function: a prospective cross-over pilot study","volume":"20","author":"Ghebremariam","year":"2015","journal-title":"Vasc. Med."},{"key":"10.1016\/j.bbagen.2022.130149_bb0215","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-153-6-201009210-00005","article-title":"Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study","volume":"153","author":"Charlot","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbagen.2022.130149_bb0220","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/ATVBAHA.107.156596","article-title":"Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg","volume":"28","author":"Leong","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbagen.2022.130149_bb0225","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/ijms17040454","article-title":"Asymmetric Dimethylarginine versus proton pump inhibitors usage in patients with stable coronary artery disease: a cross-sectional study","volume":"17","author":"Kruszelnicka","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2022.130149_bb0230","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1038\/s41598-017-03069-1","article-title":"Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance","volume":"7","author":"Tommasi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2022.130149_bb0235","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2022.130149_bb0240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1107\/S0021889800018227","article-title":"Global indicators of X-ray data quality","volume":"34","author":"Weis","year":"2001","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bbagen.2022.130149_bb0245","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1218231","article-title":"Linking crystallographic model and data quality","volume":"336","author":"Karplus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2022.130149_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416522000678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416522000678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:13:40Z","timestamp":1759637620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416522000678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0304416522000678"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2022.130149","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esomeprazole covalently interacts with the cardiovascular enzyme dimethylarginine dimethylaminohydrolase: Insights into the cardiovascular risk of proton pump inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2022.130149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"130149"}}